CBT

CBT Intangible Assets

$52.00MQuarterly · USD

Period ending:

CBT FY Intangible AssetsUSD
CBT FY Intangible Assets1985-09-30: $21.60M1986-09-30: $19.00M1987-09-30: $16.10M1988-09-30: $13.00M1989-09-30: $16.80M1990-09-30: $104.50M1991-09-30: $97.60M1992-09-30: $87.40M1993-09-30: $78.90M1994-09-30: $74.10M1995-09-30: $13.90M1996-09-30: $42.70M1997-09-30: $39.10M1998-09-30: $24.20M1999-09-30: $20.00M2000-09-30: $21.00M2001-09-30: $21.00M2002-09-30: $113.00M2003-09-30: $119.00M2004-09-30: $118.00M2005-09-30: $31.00M2006-09-30: $5.00M2007-09-30: $4.00M2008-09-30: $3.00M2009-09-30: $2.00M2010-09-30: $4.00M2011-09-30: $3.00M2012-09-30: $330.00M2013-09-30: $310.00M2014-09-30: $347.00M2015-09-30: $153.00M2016-09-30: $140.00M2017-09-30: $137.00M2018-09-30: $98.00M2019-09-30: $96.00M2020-09-30: $103.00M2021-09-30: $100.00M2022-09-30: $63.00M2023-09-30: $60.00M2024-09-30: $53.00M2025-09-30: $55.00M$347.00M$0.00
1985-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CBT intangible assets history

Patents, trademarks, and other intangible assets. The available annual fiscal periods series contains 41 observations from Sep 30, 1985 to Sep 30, 2025.

Cabot Corp Intangible Assets — Annual fiscal periods (USD)
Period endingIntangible Assets (USD)
55,000,000
53,000,000
60,000,000
63,000,000
100,000,000
103,000,000
96,000,000
98,000,000
137,000,000
140,000,000
153,000,000
347,000,000
310,000,000
330,000,000
3,000,000
4,000,000
2,000,000
3,000,000
4,000,000
5,000,000
31,000,000
118,000,000
119,000,000
113,000,000
21,000,000
21,000,000
20,000,000
24,200,000
39,100,000
42,700,000
13,900,000
74,100,000
78,900,000
87,400,000
97,600,000
104,500,000
16,800,000
13,000,000
16,100,000
19,000,000
21,600,000

Compare intangible assets

All CBT financial metrics · CBT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.